Therapy of Fabry disease with pharmacological chaperones: from in silico predictions to in vitro tests

BACKGROUND: Fabry disease is a rare disorder caused by a large variety of mutations in the gene encoding lysosomal alpha-galactosidase. Many of these mutations are unique to individual families. Fabry disease can be treated with enzyme replacement therapy, but a promising novel strategy relies on sm...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Andreotti, Giuseppina, Citro, Valentina, De Crescenzo, Agostina, Orlando, Pierangelo, Cammisa, Marco, Correra, Antonella, Cubellis, Maria Vittoria
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2011
Ämnen:
Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3216245/
https://ncbi.nlm.nih.gov/pubmed/22004918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-1172-6-66
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk